as 07-26-2024 4:00pm EST
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.
Founded: | 1997 | Country: | United States |
Employees: | N/A | City: | SOUTH ORANGE |
Market Cap: | 22.2M | IPO Year: | 2004 |
Target Price: | $5.00 | AVG Volume (30 days): | 9.5K |
Analyst Decision: | Buy | Number of Analysts: | 1 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.14 | EPS Growth: | N/A |
52 Week Low/High: | $1.35 - $4.04 | Next Earning Date: | 08-07-2024 |
Revenue: | $14,063,000 | Revenue Growth: | 22.14% |
Revenue Growth (this year): | 14.55% | Revenue Growth (next year): | 12.91% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Amron Arthur H | NEPH | Director | May 28 '24 | Buy | $2.22 | 2,000 | $4,441.40 | 100,463 | SEC Form 4 |
Amron Arthur H | NEPH | Director | May 28 '24 | Buy | $2.24 | 3,000 | $6,734.70 | 103,463 | SEC Form 4 |
Banks Robert R. Jr. | NEPH | President and CEO | May 14 '24 | Buy | $2.24 | 50,000 | $112,050.00 | 70,000 | SEC Form 4 |
Amron Arthur H | NEPH | Director | Mar 12 '24 | Buy | $2.45 | 7,000 | $17,129.70 | 7,000 | SEC Form 4 |
Banks Robert R. Jr. | NEPH | President and CEO | Dec 7 '23 | Buy | $2.20 | 18,000 | $39,646.80 | 20,000 | SEC Form 4 |
NEPH Breaking Stock News: Dive into NEPH Ticker-Specific Updates for Smart Investing
Simply Wall St.
a month ago
PR Newswire
2 months ago
Business Wire
2 months ago
Business Wire
2 months ago
Reuters
2 months ago
Investor's Business Daily
2 months ago
GlobeNewswire
2 months ago
Business Wire
2 months ago
The information presented on this page, "NEPH Nephros Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.